Zealand Pharma — December 2023
-
Nyheden omkring Pfizer igår kunne give indtryk af selskabet dropper ud af det terapeutiske område for fedme. Men det er faktiske sådan at Pfizer på samme aktive lægemiddelstof har et kliniske udviklingsprogram men med anndet behandlingsregime. Men selskabet kommer senere på markedet og de har mindre strenge at spille på.
-
Pfizer skulle efter sigende have en bred prækliniske obesity pipeline. Men præklinisk = mindst 7 år fra markedet. Med mindre deres once per day formlering virker efter hensigten. Så er de vel 6 år fra markedet. Så om alle omstændigheder omkring 2030. 2030 hvor flere analytiker nu estimere et fedme marked på $100 mia
-
Mandagens danske avisuddrag med Ørsted, Zealand Pharma og Tesla https://www.proinvestor.com/investornyt/1085630/mandagens-danske-avisuddrag-med-orsted-zealand-pharma-og-tesla
-
Shortpositioner på danske aktier mandag d. 4. december 2023https://www.proinvestor.com/boards/117056
-
Fedmemarkedet ses tæt på fordoblet i 2024: Novo i førersædet, mener BI https://www.proinvestor.com/investornyt/1085637/fedmemarkedet-ses-taet-pa-fordoblet-i-2024-novo-i-forersaedet-mener-bi
-
Læg den bare ind for sig exitnu.
-
Zealand Pharma to highlight obesity pipeline at R&D Event on December 5
Event to be hosted by company management and feature key external scientific and clinical experts
-
To register, please go to Zealand Pharma’s website at https://www.zealandpharma.com/event/zealand-pharmas-obesity-rd-event/.
-
A replay will be made available after the live event, along with presentation materials.
-
Mornings og tak
-
nedtælling til R&D i morgen!
-
Og ny
ATH intraday i 346,2 -
Højere bunde og toppe….ser lovende ud
-
Roche To Acquire Carmot Therapeutics For $2.7 Bln Cash Plus Milestone Payments (https://www.proinvestor.com/investornyt/1085639/roche-to-acquire-carmot-therapeutics-for-27-bln-cash-plus-milestone-payments
-
"Berkeley, California -based Carmot holds three clinical stage assets with best-in-class potential in obesity and diabetes".
-
ATH intraday idag
347,80
-
dejligt - god aften - spændende tirsdag venter
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind